RSV F protein mutants

US10821171B2 · kind B2 · utility

Assignee

• PFIZER INC. · US

Inventors

• Ye Che · Groton, US
• Philip Dormitzer · Cambridge, US
• Alexey Vyacheslavovich Gribenko · New City, US
• Luke David Handke · Nyack, US
• Avvari Krishna Prasad · Chapel Hill, US
• Xiayang Qiu · Mystic, US
• Mark Edward Ruppen · Garnerville, US
• Xi Song · Hong Kong, CN
• Kena Anne Swanson · Pearl River, US
• Srinivas Kodali
• Xin Xu · Dongying, CN
• KariAnn Sweeney Efferen · Stamford, US
• Ping Cai · New City, US
• Kristin Rachael Tompkins · Garrison, US
• Lorna del Pilar Nunez · Briarcliff Manor, US

Key dates

• Filing date: Jan 8, 2019
• Grant date: Nov 3, 2020
• Expiry date: Jan 8, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/18571
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.